Jorge González-Zabaleta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jorge González-Zabaleta has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Beatriz López-Calviño
Clinical Epidemiology and Biostatistics Research Group, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), SERGAS, Universidade da Coruña, A Coruña, Spain
2 shared publications - Jose Luis Gonzalez-Zabaleta
Modelo Hospital, HM Hospitals, Surbone Clinic, A Coruña, Spain
2 shared publications - Teresa Seoane-Pillado
Preventive Medicine and Public Health Unit, Department of Health Sciences, University of A Coruña-INIBIC, A Coruña, Spain
2 shared publications Salvador Pita-Fernandez
Clinical Epidemiology and Biostatistics Research Group, Biomedical Research Institute of A Coruña (INIBIC), A Coruña Hospital (CHUAC), SERGAS, University of A Coruña, 15006 A Coruña, Spain
1 shared publicationSalvador Pita‐Fernandez
Clinical Epidemiology and Biostatistics Research Group, Biomedical Research Institute of A Coruña (INIBIC), A Coruña Hospital (CHUAC), SERGAS, University of A Coruña, A Coruña, Spain
1 shared publication
Latest Publications
- 15 May 2015
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 16 (5) , 561-569
Comorbidity as a predictor of mortality and mobility after hip fracture
Aim: To determine mortality and mobility rates after hip fracture.Methods: A prospective study (n = 199 patients) was carried out in the Health Care Center of A Coruña (Spain) during the period between January 2009 and December 2011. A descriptive study, and Cox and logistic regression analysis were carried out. Informed consent and ethical review board approval were obtained (code 2010/120 CEIC Galicia).Results: The patients' mean age was 82.5 ± 8.4 years and 76% were female. The average Charlson Comorbidity Index score was 6.1 ± 2.1. Creatinine clearance 2 was 44%. The probability of survival 6 months after hip fracture was 89.2% and the survival rate at 12 months was 81.4%. Cox regression analysis showed that the indicator that most influenced mortality rate was comorbidity (HR = 1.133; P = 0.020) and age approaching borderline statistical significance (HR = 1.034; P = 0.064). The Parker Mobility Score decreased significantly (P < 0.001) after hip fracture. Before fracture, 19% of the patients were able to get about the house, 26% were able to get out of the house and 55% were able to go shopping. After hip fracture (90 days), the percentages changed to 56.2%, 19.1% and 24.7%, respectively (P < 0.001). After taking into account age, sex, type of fracture, surgical delay, previous fracture and comorbidity, the only indicator capable of predicting incapacity to walk was comorbidity.Conclusions: Comorbidity is the best predictor of mortality and mobility after hip fracture. Geriatr Gerontol Int 2016; 16: 561–569.
- 15 May 2015
- Published by Wiley in Geriatrics & Gerontology International
- Vol. 16 (5) , 561-569
Comorbidity as a predictor of mortality and mobility after hip fracture
Aim: To determine mortality and mobility rates after hip fracture.Methods: A prospective study (n = 199 patients) was carried out in the Health Care Center of A Coruña (Spain) during the period between January 2009 and December 2011. A descriptive study, and Cox and logistic regression analysis were carried out. Informed consent and ethical review board approval were obtained (code 2010/120 CEIC Galicia).Results: The patients' mean age was 82.5 ± 8.4 years and 76% were female. The average Charlson Comorbidity Index score was 6.1 ± 2.1. Creatinine clearance 2 was 44%. The probability of survival 6 months after hip fracture was 89.2% and the survival rate at 12 months was 81.4%. Cox regression analysis showed that the indicator that most influenced mortality rate was comorbidity (HR = 1.133; P = 0.020) and age approaching borderline statistical significance (HR = 1.034; P = 0.064). The Parker Mobility Score decreased significantly (P < 0.001) after hip fracture. Before fracture, 19% of the patients were able to get about the house, 26% were able to get out of the house and 55% were able to go shopping. After hip fracture (90 days), the percentages changed to 56.2%, 19.1% and 24.7%, respectively (P < 0.001). After taking into account age, sex, type of fracture, surgical delay, previous fracture and comorbidity, the only indicator capable of predicting incapacity to walk was comorbidity.Conclusions: Comorbidity is the best predictor of mortality and mobility after hip fracture. Geriatr Gerontol Int 2016; 16: 561–569.
- 1 January 2015
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 60 (1) , 66-70
Dependence for basic and instrumental activities of daily living after hip fractures
- 1 January 2015
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 60 (1) , 66-70
Dependence for basic and instrumental activities of daily living after hip fractures